National Institute of Health and Care Excellence (NICE)
80 episodes
6 days ago
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
All content for NICE Talks is the property of National Institute of Health and Care Excellence (NICE) and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
Assessing the familial and genetic risk of ovarian cancer
NICE Talks
15 minutes 2 seconds
1 year ago
Assessing the familial and genetic risk of ovarian cancer
Following the publication of our new guideline, ovarian cancer: identifying and managing familial and genetic risk, the latest episode of NICETalks focuses on genetic testing and how it can help to identify those most at risk of ovarian cancer.
We talk to Ranjit Manchanda, professor of gynaecological oncology, Queen Mary University of London and Barts Health NHS Trust, Dr Judith Hayward, GP with special interest in genetics and Joanne Stanford who joined us to share her personal experience of genetic testing.
NICE Talks
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.
Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
